Phosphatases, in vitro:
PPP2CA T516-p , S520-p
Putative upstream phosphatases:
PPP2CA T516-p , S520-p
Regulatory protein:
PPM1B T516-p , S520-p
PPM1J T516-p , S520-p
PPM1K T516-p , S520-p
PPM1M T516-p , S520-p
PPP2CA T516-p , S520-p
PPP3CB T516-p , S520-p
PPP5C T516-p , S520-p
PPP6C T516-p , S520-p
PPPM1A T516-p , S520-p
PPTC7 T516-p , S520-p
Treatment:
angiotensin_2 S166-p , S337-p , S340-p
BI2536 S340-p , S345-p
ionomycin T516-p , S520-p
ischemia S176-p
LPA S340-p , T516-p , S520-p
LPS T294-p , S526-p
MG132_withdrawal S337-p
okadaic_acid S526-p
phorbol_ester T516-p , S520-p
selumetinib S337-p , S340-p
SII_angiotensin_2 S166-p , S337-p , S340-p
TNF T294-p
vemurafenib S337-p , S340-p